Global Pharmacogenomics Market to reach a market size of $9.9 billion by 2025- KBV Research

Global Pharmacogenomics Market to reach a market size of $9.9 billion by 2025- KBV Research

According to a new report Global Pharmacogenomics Market, published by KBV research, The Global Pharmacogenomics Market size is expected to reach $9.9 billion by 2025, rising at a market growth of 8.8% CAGR during the forecast period.


The Hospitals and Clinics market dominated the Global Pharmacogenomics Market by End User in 2018, growing at a CAGR of 8.5 % during the forecast period. The Research Institutions market is expected to witness highest CAGR of 9.1% during (2019-2025)


The North America market dominated the Global Infectious Diseases Market by Region in 2018, growing at a CAGR of 9.1 % during the forecast period. The Europe market is expected to witness a CAGR of 9.3% during (2019-2025). Additionally, The Asia Pacific market is expected to witness a CAGR of 11.2% during (2019-2025).


The Sequencing market in the Global Pharmacogenomics Market by Technology would grow at a CAGR of 8 % during the forecast period. The Polymerase Chain Reaction market is expected to witness a CAGR of 8.1% during (2019-2025).


Full Report: https://www.kbvresearch.com/pharmacogenomics-market/


The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, Empire Genomics LLC, Illumina, Inc., oneome LLC, Myriad Genetics Inc., Thermo Fisher Scientific, Inc., Teva Pharmaceuticals Industries Ltd., Bayer AG, Opko Health, Inc., and Becton, Dickinson and Company.


Global Pharmacogenomics Market Segmentation


By Technology


Sequencing


Polymerase Chain Reaction


Electrophoresis


Mass Spectrometry


Microarray


Others


By Application


Oncology


Psychiatry


Infectious Diseases


Neurological Diseases


Pain management


Cardiovascular Diseases


Others


By End User


Hospitals and Clinics


Research Institutions


Academic Institutes


By Geography


North America


US


Canada


Mexico


Rest of North America


Europe


Germany


UK


France


Russia


Spain


Italy


Rest of Europe


Asia Pacific


China


Japan


India


South Korea


Singapore


Malaysia


Rest of Asia Pacific


LAMEA


Brazil


Argentina


UAE


Saudi Arabia


South Africa


Nigeria


Rest of LAMEA


Companies Profiled


Abbott Laboratories


Empire Genomics LLC


Illumina, Inc.


Oneome LLC


Myriad Genetics Inc.


Thermo Fisher Scientific, Inc.


Teva Pharmaceuticals Industries Ltd.


Bayer AG


Opko Health, Inc.


Becton, Dickinson and Company


Unique Offerings from KBV Research


Exhaustive coverage


Highest number of market tables and figures


Subscription based model available


Guaranteed best price


Assured post sales research support with 10% customization free


Pharmacogenomics Market Related Reports:


North America Market


Europe Market


Asia Pacific Market


LAMEA Market


 

FECHA: a las 14:56h (86 Lecturas)

TAGS: Pharmacogenomics, Pharmacogenomics Market, KBV Research

EN: Ciencia y tecnología